Company profile
Synthena company profile
Synthena is a development stage biotechnology company aiming to develop and commercialize new life saving drugs for the treatment of severe neuromuscular diseases based on the modulation of RNA. Its proprietary tricyclo-DNA technology platform offers broad advantages over state of the art oligonucleotide chemistries for new RNA intervention strategies like splice switching, and other antisense approaches. Its most advanced preclinical drug development program focuses on Duchenne Muscular Dystrophy, a genetic disorder which affects 1/3,500 boys and which leads to death in early adulthood.
Business identity
- Website
- http://www.synthena.com
- Contact email
- [email protected]
- Phone number
- +41(0) 31 631 4265
- Operating status
- Active
- Company type
- For Profit
Headquarters
- Headquarters
- Bulle, Fribourg, Switzerland
- Postal code
- 3012
- Country code
- CH
- Continent
- Europe